Literature DB >> 12466233

Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venules.

R E Young1, R D Thompson, S Nourshargh.   

Abstract

1. Protein synthesis dependency and the role of endogenously generated platelet activating factor (PAF) and leukotriene B(4) (LTB(4)) in leukocyte migration through interleukin-1beta (IL-1beta)- and tumour necrosis factor-alpha (TNFalpha)-stimulated mouse cremasteric venules was investigated using established pharmacological interventions and the technique of intravital microscopy. 2. Based on previously obtained dose-response data, 30 ng rmIL-1beta and 300 ng rmTNFalpha were injected intrascrotally (4 h test period) to induce comparable levels of leukocyte firm adhesion and transmigration in mouse cremasteric venules. 3. Co-injection of the mRNA synthesis inhibitor, actinomycin D (0.2 mg kg(-1)), with the cytokines significantly inhibited firm adhesion (49+/-13.6%) and transmigration (67.2+/-4.2%) induced by IL-1beta, but not TNFalpha. 4. In vitro, TNFalpha (1-100 ng ml(-1)), but not IL-1beta, stimulated L-selectin shedding and increased beta(2) integrin expression on mouse neutrophils, as quantified by flow cytometry. 5. The PAF receptor antagonist, UK-74,505 (modipafant, 0.5 mg kg(-1), i.v.), had no effect on adhesion induced by either cytokine, but significantly inhibited transmigration induced by IL-1beta (66.5+/-4.5%). 6. The LTB(4) receptor antagonist, CP-105,696 (100 mg kg(-1), p.o.), significantly inhibited both IL-1beta induced adhesion (81.4+/-15.2%) and transmigration (58.7+/-7.2%), but had no effect on responses elicited by TNFalpha. Combined administration of the two antagonists had no enhanced inhibitory effects on responses induced by either cytokine. 7. The data indicate that firm adhesion and transmigration in mouse cremasteric venules stimulated by IL-1beta, but not TNFalpha, is protein synthesis dependent and mediated by endogenous generation of PAF and LTB(4). Additionally, TNFalpha but not IL-1beta, can directly stimulate mouse neutrophils in vitro. The findings provide further evidence to suggest divergent mechanisms of actions of IL-1beta and TNFalpha, two cytokines often considered to act via common molecular/cellular pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466233      PMCID: PMC1573606          DOI: 10.1038/sj.bjp.0704981

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  64 in total

1.  Activation of human neutrophil by cytokine-activated endothelial cells.

Authors:  T Takahashi; F Hato; T Yamane; H Fukumasu; K Suzuki; S Ogita; Y Nishizawa; S Kitagawa
Journal:  Circ Res       Date:  2001-03-02       Impact factor: 17.367

2.  Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane.

Authors:  R D Thompson; K E Noble; K Y Larbi; A Dewar; G S Duncan; T W Mak; S Nourshargh
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

Review 3.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

4.  Interleukin-1beta-induced type IIA secreted phospholipase A2 gene expression and extracellular activity in rat vascular endothelial cells.

Authors:  M Schwemmer; H Aho; J B Michel
Journal:  Tissue Cell       Date:  2001-06       Impact factor: 2.466

Review 5.  Biologic agents in the treatment of rheumatoid arthritis.

Authors:  B Haraoui; V Strand; E Keystone
Journal:  Curr Pharm Biotechnol       Date:  2000-11       Impact factor: 2.837

Review 6.  Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis.

Authors:  M H Schiff
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

7.  Lymphocyte function antigen 1 (LFA-1) mediates early tumour necrosis factor alpha-induced leucocyte adhesion in venules.

Authors:  H Thorlacius; B Vollmar; Y Guo; T W Mak; M M Pfreundschuh; M D Menger; R Schmits
Journal:  Br J Haematol       Date:  2000-08       Impact factor: 6.998

8.  Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis.

Authors:  C M Huang; F J Tsai; J Y Wu; M C Wu
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

9.  Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha.

Authors:  G Alloatti; C Penna; F Mariano; G Camussi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-12       Impact factor: 3.619

Review 10.  Interleukin-1 in the pathogenesis of and protection from inflammatory bowel disease.

Authors:  F Cominelli; C A Dinarello
Journal:  Biotherapy       Date:  1989
View more
  11 in total

1.  TNF regulates leukocyte-endothelial cell interactions and microvascular dysfunction during immune complex-mediated inflammation.

Authors:  M Ursula Norman; Karyn J Lister; Yuan H Yang; Andrew Issekutz; Michael J Hickey
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

2.  Differing mechanisms of leukocyte recruitment and sensitivity to conditioning by shear stress for endothelial cells treated with tumour necrosis factor-alpha or interleukin-1beta.

Authors:  Sajila Sheikh; Mahbub Rahman; Zoe Gale; N Thin Luu; Philip C W Stone; Nick M Matharu; G Edward Luu Rainger; Gerard B Nash
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

3.  Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells.

Authors:  S H P Oliveira; C Canetti; R A Ribeiro; F Q Cunha
Journal:  Inflammation       Date:  2008-02       Impact factor: 4.092

4.  Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1.

Authors:  Abigail Woodfin; Mathieu-Benoit Voisin; Beat A Imhof; Elisabetta Dejana; Britta Engelhardt; Sussan Nourshargh
Journal:  Blood       Date:  2009-02-10       Impact factor: 22.113

5.  Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice.

Authors:  Cristiana C Garcia; Remo C Russo; Rodrigo Guabiraba; Caio T Fagundes; Rafael B Polidoro; Luciana P Tavares; Ana Paula C Salgado; Geovanni D Cassali; Lirlândia P Sousa; Alexandre V Machado; Mauro M Teixeira
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

6.  Spatial regulation of inflammation by human aortic endothelial cells in a linear gradient of shear stress.

Authors:  Jean K Tsou; R Michael Gower; Harold J Ting; Ulrich Y Schaff; Michael F Insana; Anthony G Passerini; Scott I Simon
Journal:  Microcirculation       Date:  2008-05       Impact factor: 2.628

7.  LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration.

Authors:  Lixin Liu; Denise C Cara; Jaswinder Kaur; Eko Raharjo; Sarah C Mullaly; Jenny Jongstra-Bilen; Jan Jongstra; Paul Kubes
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

8.  C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment.

Authors:  Tracy Stokol; Peter O'Donnell; Ling Xiao; Sara Knight; George Stavrakis; Marina Botto; Ulrich H von Andrian; Tanya N Mayadas
Journal:  J Exp Med       Date:  2004-10-04       Impact factor: 14.307

9.  Galectin-3: A Positive Regulator of Leukocyte Recruitment in the Inflamed Microcirculation.

Authors:  Beatrice R Gittens; Jennifer V Bodkin; Sussan Nourshargh; Mauro Perretti; Dianne Cooper
Journal:  J Immunol       Date:  2017-04-24       Impact factor: 5.422

10.  Analysis of leukocyte rolling and migration--using inhibitors in the undisturbed microcirculation of the rat mesentery--on inflammatory stimulation.

Authors:  Yuko Takano-Ishikawa; Masao Goto; Kohji Yamaki
Journal:  Mediators Inflamm       Date:  2004-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.